Kura Oncology Ratios (2022-2026) | KURA

1Y3Y5Y7Y10YAll
Download Data
Ratios Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) 100.00%98.57%
EBT Margin (Quarter) -405.46%-432.51%-357.19%1,138.91%-401.45%
EBIT Margin (Quarter) -458.61%-429.95%-355.29%1,140.90%-431.51%
EBITDA Margin (Quarter) -405.58%-434.23%-356.19%-466.62%-409.18%
Operating Margin (Quarter) -458.61%-431.51%
Net Margin (Quarter) -407.07%-432.51%-357.19%1,138.50%-401.49%
FCF Margin (Quarter) -511.90%-197.77%-389.90%649.87%-470.75%
Efficiency
Inventory Average (Quarter) 0.63M
Assets Average (Quarter) 441.14M460.36M484.25M461.35M501.42M534.51M496.98M619.50M751.96M713.09M665.90M693.87M695.46M
Equity Average (Quarter) 407.73M427.43M444.81M413.61M451.18M485.58M444.92M418.71M389.02M334.95M274.01M208.34M141.01M
Invested Capital (Quarter) 420.28M395.18M459.68M429.94M397.27M505.08M466.92M425.49M416.25M366.33M308.60M246.88M183.84M107.88M
Asset Utilization Ratio (Quarter) 0.100.10
Leverage & Solvency
Interest Coverage Ratio (Quarter) -123.43-124.21-131.05-41.68-169.37-168.11-187.59571.64-234.57
Debt to Equity (Quarter) 0.020.020.020.020.020.020.020.020.020.030.030.040.060.09
Debt Ratio (Quarter) 0.020.020.020.020.020.020.020.020.010.010.010.010.010.01
Equity Ratio (Quarter) 0.920.930.930.910.880.910.900.890.540.490.450.370.240.17
Times Interest Earned (Quarter) -123.43-124.21-131.05-41.68-169.37-168.11-187.59571.64-234.57
Valuation
Enterprise Value (Quarter) -437.99M-405.90M-476.98M-452.59M-423.96M-527.12M-491.52M-455.30M-727.39M-658.19M-630.73M-549.66M-667.24M-580.82M
Return Ratios
Return on Sales (Quarter) -0.04%-0.04%-0.04%0.11%-0.04%
Return on Capital Employed (Quarter) -31.50%-28.08%-33.21%-40.57%-1.10%-3.45%
Return on Invested Capital (Quarter) 0.00%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter) 0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%0.00%0.00%